DE SB15 | 2019-2020 | 150th General Assembly


Spectrum: Slight Partisan Bill (Republican 17-10)
Status: Introduced on January 24 2019 - 25% progression
Action: 2019-01-24 - Introduced and Assigned to Health & Social Services Committee in Senate
Pending: Senate Health & Social Services Committee
Text: Latest bill text (Draft #1) [HTML]


This Act, modeled on similar laws in Virginia and Maryland, requires a health-care provider to provide notice to a patient at the time blood is drawn to perform a laboratory test for Lyme disease that explains the limitations of the test and instructs the patient to see their health-care provider if the patient continues to experience unexplained symptoms. This Act is consumer and patient friendly.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.


An Act To Amend Title 16 Of The Delaware Code Relating To The Provision Of Information About Lyme Disease.



2019-01-24 Introduced and Assigned to Health & Social Services Committee in Senate

Delaware State Sources

Bill Comments